0001209191-18-006224.txt : 20180131 0001209191-18-006224.hdr.sgml : 20180131 20180131163819 ACCESSION NUMBER: 0001209191-18-006224 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180129 FILED AS OF DATE: 20180131 DATE AS OF CHANGE: 20180131 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KELLOGG PETER N CENTRAL INDEX KEY: 0001226287 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34912 FILM NUMBER: 18563248 MAIL ADDRESS: STREET 1: MERCK & CO., INC STREET 2: ONE MERCK DRIVE., P.O. BOX 100 CITY: WHITEHOUSE STATION STATE: NJ ZIP: 08889-0100 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CELGENE CORP /DE/ CENTRAL INDEX KEY: 0000816284 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 222711928 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 86 MORRIS AVENUE CITY: SUMMIT STATE: NJ ZIP: 07901 BUSINESS PHONE: (908)673-9000 MAIL ADDRESS: STREET 1: 86 MORRIS AVENUE CITY: SUMMIT STATE: NJ ZIP: 07901 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-01-29 0 0000816284 CELGENE CORP /DE/ CELG 0001226287 KELLOGG PETER N C/O CELGENE CORPORATION 86 MORRIS AVENUE SUMMIT NJ 07901 0 1 0 0 See Remarks Stock Option (right to buy) 103.26 2018-01-29 4 A 0 13377 0.00 A 2028-01-29 Common Stock 13377 13377 D Option is immediately exercisable and will vest as follows: 3,344 shares on January 29, 2019; 3,344 shares on January 29, 2020; 3,344 shares on January 29, 2021; and 3,345 shares on January 29, 2022. The option was issued pursuant to the Company's 2017 Stock Incentive Plan. Executive Vice President and Chief Financial Officer /s/ Peter N. Kellogg 2018-01-31